Home › Type 2 Diabetes › Texas
Type 2 Diabetes clinical trials in Texas
59 studies for Type 2 Diabetes are looking for participants at sites in Texas.
Cities in Texas
- San Antonio37 studies
- Houston31 studies
- Dallas18 studies
- Austin14 studies
- Mesquite8 studies
- The Woodlands8 studies
- Pharr7 studies
- McKinney6 studies
- Lewisville5 studies
- Fort Worth5 studies
- Corpus Christi5 studies
- Sugar Land5 studies
- Grand Prairie4 studies
- Round Rock4 studies
- Killeen4 studies
- Cypress4 studies
- Brownsville4 studies
- El Paso3 studies
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Texas Diabetes and Endocrinology, Austin
- Diabetes and Glandular Disease Clinic, San Antonio
Recruiting
Ages 2 to 80 · All sexes · Updated Nov 13, 2026 · NCT07864168A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Texas Diabetes and Endocrinology - Central Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Privia Medical Group Gulf Coast, PLLC, Conroe
- and 10 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Clinical Research - Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Headlands Research - Brownsville, Brownsville
- and 25 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07064473A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
- Research Site, San Antonio
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07024823Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
RecruitingHealthy volunteers welcomeMentions payment for participants
Ages 14 to 16 · All sexes · Updated Nov 9, 2026 · NCT06943001A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Headlands Research Brownsville, Brownsville
- Velocity Clinical Research, Dallas
- South Texas Research Institute - Edinburg, Edinburg
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351058A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Gadolin Research, Beaumont
- Driscoll Children's Hospital, Corpus Christi
- Proactive Clinical Research LLC, Edinburg
- and 2 more
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Nov 5, 2026 · NCT07668336A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Diabetes and Thyroid Center of Ft. Worth, Fort Worth
- Juno Research, Houston
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07881458A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
- Velocity Clinical Research, Dallas, Dallas
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Juno Research, Houston
- Southern Endocrinology Associates, Mesquite
- Texas Diabetes & Endocrinology, P.A., Round Rock
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Dallas
- Research Site, McKinney
- Research Site, Paris
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, DeSoto
- Research Site, El Paso
- Research Site, Houston
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Arlington Nephrology, PLLC., Arlington
- M3 Wake Research Dallas - Internal Medicine, Dallas
- Revival Research Institute, LLC, Dallas
- and 10 more
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 27, 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Dallas
- Research Site, Houston
- Research Site, Houston
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07662213Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Elligo Health Research, Inc., Austin
- Zenos Clinical Research, Dallas
- Synergy Group Medical, Houston
- and 3 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 20, 2026 · NCT07502508Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- DM Clinical Research, Tomball
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07527650A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Amir Ali Hassan, MD, PA, Houston
- Consano Clinical Research, LLC, Shavano Park
RecruitingPhase 3
Ages 10 to 18 · All sexes · Updated Oct 19, 2026 · NCT07282613The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Elevate Clinical Research, Atascocita, Atascocita
- M3 Wake Research, Dallas
- Epic Medical Research, DeSoto
- and 4 more
Recruiting
Ages 22 to 65 · All sexes · Updated Oct 13, 2026 · NCT04101669A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- IMA Clinical Research, Austin
- Private Practice - Dr. Laila A. Hassan, Houston
- Radiance Clinical Research, Lampasas
- and 3 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 7, 2026 · NCT07668388Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Austin, Austin
- Velocity Clinical Research - Dallas, Dallas
- Juno Research, LLC, Houston
- and 8 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT07296484Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
- University Health - Texas Diabetic Institute, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Oct 5, 2026 · NCT06706284Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Elligo Clinical Research Center, Austin
- Johnson County Clinical Trials Juno Bellaire, Bellaire
- Osvaldo A Brusco MD PA, Corpus Christi
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684144Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- Baylor Scott & White, Temple
Recruiting
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- Houston Methodist, Houston
- Baylor Scott & White, Temple
Recruiting
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06906640Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Amarillo Med Spec LLP, Amarillo
- Texas Diabetes & Endocrinology, Austin
- North Texas Endocrine Center, Dallas
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07817251NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
Recruiting
All ages · All sexes · Updated Sep 29, 2026 · NCT06593327A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Hendrick Health, Abilene
- Gadolin Research, Beaumont
- CardioVoyage, LLC, Greenville
- and 10 more
RecruitingHealthy volunteers welcome
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- The University of Texas Health Science Center at San Antonio, San Antonio
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT02969798A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Austin
- AURORA-2 Clinical Site, Brownsville
- AURORA-2 Clinical Site, DeSoto
- and 10 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- University of Texas Southwestern Medical Center, Dallas
- JCCT- Juno NW Houston, Houston
- Consano Clinical Research, LLC, Shavano Park
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 11, 2026 · NCT07415954A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- PharmaTex Research, Amarillo
- Pinnacle Clinical Research, Austin
- Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
- and 20 more
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Irving
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662044Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Texas Diabetes & Endocrinology, Austin
Recruiting
Ages 18 to 80 · All sexes · Updated Aug 28, 2026 · NCT07599982Quantifying Hepatic Mitochondrial Fluxes in Humans
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Aug 17, 2026 · NCT05305287A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Research Institute of Dallas, Dallas
- Texas Childrens Hospital, Houston
- UT Health Houston, Houston
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 7, 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Houston
- Research Site, Round Rock
- Research Site, San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07664553From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.